Literature DB >> 15846257

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

Kirkwood F Adams1, Gregg C Fonarow, Charles L Emerman, Thierry H LeJemtel, Maria Rosa Costanzo, William T Abraham, Robert L Berkowitz, Marie Galvao, Darlene P Horton.   

Abstract

BACKGROUND: The ADHERE is designed to study characteristics, management, and outcomes in a broad sample of patients hospitalized with acute decompensated heart failure. Heart failure is a leading cause of hospitalization for adults older than 65 years in the United States. Most available data on these patients are limited by patient selection criteria and study design of clinical trials and single-center studies.
METHODS: Participating hospitals identify patients with a primary or secondary discharge diagnosis of heart failure. Medical history, management, treatments, and health outcomes data are collected through review of medical records and entered into a database via secure web browser technology.
RESULTS: As of January 2004, data on 107 362 patients have been received from 282 participating hospitals. Of enrollees with available analyzable data (N = 105 388 from 274 hospitals), the mean age was 72.4 (+/-14.0), and 52% were women. The most common comorbid conditions were hypertension (73%), coronary artery disease (57%), and diabetes (44%). Evidence of mild or no impairment of systolic function was found in 46% of patients. Inhospital mortality was 4.0% and the median hospital length of stay was 4.3 days.
CONCLUSIONS: The ADHERE demonstrates both the feasibility and significant implications of gathering representative data on large numbers of patients hospitalized with heart failure. Initial data provided important insights into the clinical characteristics and patterns of care of these patients. Ongoing registry work will provide the framework for improved treatment strategies for patients hospitalized with decompensated heart failure.

Entities:  

Mesh:

Year:  2005        PMID: 15846257     DOI: 10.1016/j.ahj.2004.08.005

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  539 in total

1.  The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with congestive heart failure: a study in Beijing.

Authors:  Qiaoxiang Yin; Yusheng Zhao; Jiayue Li; Qiao Xue; Xingli Wu; Lei Gao; Ping He; Mei Zhu; Shiwen Wang
Journal:  Clin Cardiol       Date:  2011-05-31       Impact factor: 2.882

2.  Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.

Authors:  Larry A Allen; Aslan T Turer; Tracy Dewald; Wendy Gattis Stough; Gadi Cotter; Christopher M O'Connor
Journal:  Am J Cardiol       Date:  2010-04-27       Impact factor: 2.778

3.  A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.

Authors:  Mihai Gheorghiade; Peter S Pang; Andrew P Ambrosy; Gloria Lan; Philip Schmidt; Gerasimos Filippatos; Marvin Konstam; Karl Swedberg; Thomas Cook; Brian Traver; Aldo Maggioni; John Burnett; Liliana Grinfeld; James Udelson; Faiez Zannad
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

4.  Prognostic Significance of Low Systolic Blood Pressure at Discharge in Patients with Heart Failure and Preserved Ejection Fraction.

Authors:  Shijun Li; Xiaoying Li
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-19

Review 5.  A perspective on diuretic resistance in chronic congestive heart failure.

Authors:  Niel Shah; Raef Madanieh; Mehmet Alkan; Muhammad U Dogar; Constantine E Kosmas; Timothy J Vittorio
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-07-20

6.  Trends in prevalence of comorbidities in heart failure clinical trials.

Authors:  Muhammad Shahzeb Khan; Ayman Samman Tahhan; Muthiah Vaduganathan; Stephen J Greene; Alaaeddin Alrohaibani; Stefan D Anker; Orly Vardeny; Gregg C Fonarow; Javed Butler
Journal:  Eur J Heart Fail       Date:  2020-04-15       Impact factor: 15.534

7.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

Review 8.  Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.

Authors:  Ralf Wassmuth
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

Review 9.  Right Heart Failure and Cardiorenal Syndrome.

Authors:  Thida Tabucanon; Wai Hong Wilson Tang
Journal:  Cardiol Clin       Date:  2020-03-02       Impact factor: 2.213

10.  Prognostic value of increased carbohydrate antigen in patients with heart failure.

Authors:  Ana B Méndez; Jordi Ordoñez-Llanos; Andreu Ferrero; Mariana Noguero; Teresa Mir; Josefina Mora; Antoni Bayes-Genis; Sònia Mirabet; Juan Cinca; Eulàlia Roig
Journal:  World J Cardiol       Date:  2014-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.